Background: Escherichia coli (E.coli) has been implicated as a common cause of both early and late onset neonatal infections. The emergence of different strains of E.coli that are multiply resistant to commonly used antibiotics has made continuous antibiotics surveillance relevant. Knowledge about common infections caused by E.coli as well as its antibiotics susceptibility pattern will guide paediatricians in choosing appropriate antibiotics for empirical treatment of neonatal infections.
INTRODUCTION
Infections have been identified as the most common cause of death in the neonatal period in both developed and developing countries (1, 2) . These infections include neonatal sepsis, meningitis, pneumonia, and soft tissue infections. Escherichia coli (E.coli) has been implicated as one of the most common isolates recovered from specimen submitted for processing due to infection in this age group (1) .It has been implicated as a common cause of neonatal sepsis (1, 3) , neonatal meningitis(3), neonatal bacteremia (4) , and neonatal soft tissue infection (4) . E.coli is able to cause these infections because they are among the first set of bacteria that colonize the newborn. It exists as a normal flora of the gastrointestinal tract of human (5) and can easily spread from the rectum to the female genital tract through the perineum (1, 5) . Vaginal E.coli colonization is detected in 7-13% of pregnant women and 21% in the blood of fetuses that have died during the third trimester of pregnancy (6, 7) . Neonates acquire E.coli intrapatum and during labour (5, 6, 7) .
The immune system of neonate is not fully developed at birth and till date, no preventive measures have been advocated for E.coli colonization of the birth canal (1) . E.coli and group B β-haemolytic streptococcus (GBS) are the commonest bacteria mentioned as a cause of early onset neonatal sepsis (EONS) in developed countries (8) . However, following the introduction of late antenatal screening and intrapatum antibiotics prophylaxis in 1996 which led to a reduction in GBS, the gram negative bacteria such as E.coli have become prevalent as a cause of EONS (8) . Previous studies in our center implicated E.coli, K.pneumoniae, P.aeruginosa and S.aureus as common causes of infections in the neonatal period similar to what has been reported from other centres in Nigeria (9, 10) .
The occurrence of antibiotics resistance in E.coli continue to increase nationwide both for single and to multi-class resistance to several antibiotics (multidrug resistance [MDR]) (11, 28) . The recent trend in antibiotic resistance has seen the emergence of different strains of E.coli that elaborate resistance enzymes such as Extended-Spectrum Beta Lactamases (ESBLs) producer, AmpC β-lactamases and carbapenemases that confer multiple resistance to commonly used antibiotics for treatment of infections (11, 12, 27, 28) . These have made continuous antimicrobial surveillance a priority in clinical microbiology laboratories.
The aim of this study was to evaluate the prevalence of E.coli as a cause of neonatal infections as well as their antibiotics susceptibility pattern in the last three years in NHA. The outcome of this study will guide the paediatrician in the management of suspected cases of E.coli infections, and direct further research.
METHODS
This is a retrospective study carried out at the National Hospital Abuja, a 200 bedded tertiary healthcare institution, located in the Federal Capital Territory (FCT), Nigeria. It has a well equipped Special Care Baby Unit (SCBU) and Neonatal Intensive Care Unit (NICU). The hospital serves as a tertiary healthcare and referral centre for the inhabitants of Abuja and neighboring states.
The records of the Department of Medical Microbiology and Parasitology laboratory of the hospital from Jan. 1 st 2010 to Dec. 31 st 2012 were reviewed. All isolates from blood culture, Cerebrospinal fluid (CSF) and soft tissue (wound swab, eye swab, ear swab, umbilical cord, pus) specimens from neonates that were conclusively identified as pathogens were included in the study, while contaminants were excluded. E.coli isolates were specifically reviewed with emphasis on the age, sex, type of specimen submitted to the laboratory for analysis as well as their antibiotics susceptibility pattern.
In our facility during the study period, blood cultures were usually performed with Oxoid signal system (Oxoid, Basingstoke, UK) or BACTEC 9050(BectonDickson, New Jersey, USA) continuous-monitoring blood culture systems. CSF analysis, soft tissue culture and bacterial identification were performed using standard microbiology techniques (13) . The Modified Kirby-Bauer disc diffusion method was used for antibiotics susceptibility testing and interpreted based on the Clinical and Laboratory Standard Institute (CLSI) recommendations (14) .
RESULTS
A total of 757 specimen comprising blood(245), CSF(127) and soft tissue(385) were submitted for processing during the period under review. 251(33.2%) pathogens were isolated, out of which 247 (98.4%) were bacteria isolates while 4(1.6%) were Candida species (Table 1 ). 17 (6.8%) were identified as E.coli; one from blood culture, non from CSF, 16 from soft tissue specimens (Table 2 ).
S.aureus was the predominant bacteria isolated, accounting for 143 (56.5%) of the 251 isolates and the most frequently isolated pathogen across all the specimens types submitted for processing ( Table 2) . All the 17 isolate of E.coli were from neonates older than 72hours; 8 from females and 9 from males. Wound and umbilical swabs specimen were the predominant specimen received (Table 3) . 80%, 81.8%, 83.3%, and 62.5% of the tested E.coli strains were resistant to ampicillin, amoxicillin-clavulanate, gentamicin and cefuroxime respectively, while 40%, 33.3%, 66.7% and 20% were resistant to cefotaxime, ceftriaxone, ceftazidime and imipenem respectively. All tested E.coli strains were sensitive to amikacin (Table 4) . 
DISCUSSION
It has been revealed in this study that most of the E.coli isolated were from soft tissue specimens; it is difficult to ascertain whether they represent true infections or colonization of the newborn. No conclusion can be made concerning the only isolate from blood except to say that it most probably represent a true infection. S.aureus is the most common bacteria cause of infections in this age group. It is the predominant bacterial isolate from blood culture, followed by K.pneumoniae. This finding is in agreement with similar studies from Maiduguri and Uganda on neonatal infections which showed S.aureus as the predominant pathogen, followed by Klebsiellae pneumonia (15, 16) . It however, contrast with a previous study done in this center between 2002 to 2004 which showed almost equal representation of both gram negative and gram positive bacteria as causes of neonatal sepsis(9) and a prospective study in Port Harcourt which showed Klebsiella pneumonia as the predominant isolate (17). S.aureus was the main bacteria isolated from CSF during the study period, and this is in keeping with the result of a previous study in Jos, Nigeria (18) . The same study reported the absence of E.coli from CSF (18) . E.coli is a known cause of neonatal meningitis (3). The reason for this is not clear, and may require further studies. Although, the coagulase negative staphylococci (CoNS) that were isolated were recorded as pathogens they may as well represent contaminants. Difficulties exist in some cases in the differentiation of CoNS infection from culture contamination in clinical specimen because CoNS is a common skin commensal (19) . Four of the isolates were candida specie from blood culture and soft tissue which might be responsible for infection in low birth weight neonates as observed in some previous studies (20, 21) . All the isolates in this study were from the late neonatal period and as such, it is difficult to determine whether E.coli is a common cause of infection in the early neonatal period or not. It is possible that delays in decision making by the paediatrician with respect to submission of neonatal specimen for analysis whenever they suspect neonatal infection within 72 hours, may have inadvertently moved early onset infections into late onset period.
The antibiotics resistant pattern in the E.coli isolated in this study cannot be interpreted with a high degree of certainty because not all the isolates were equally tested for resistance to the same classes of commonly used antibiotics in our laboratory. However, based on the available data, most of the isolates are resistant to amoxicillin, amoxicillin-clavulanate in agreement with previous studies (9, 22, 23) . Most were also resistance to the third generation cephalosporins with few of the E.coli isolates showing resistant pattern resembling ESBL producers; the prevalence of which has been reported in other studies as11.4% (2009)and 3.8%(2012) by Iroha et al from Enugu (24, 25) , while 76.9% was report from Ibadan in 2012 (28) . The tested isolates were susceptible to imipenem and this agrees with previous studies (9, 25, 26, 27) . This may suggest that strains that elaborates carbapenemase enzyme may not be common in this locality. Studies have shown that most Enterobacteriaceae, E.coli inclusive; even the ESBL-producing strains, are still susceptible to the carbapenems (25, 26, 27, 28) .
Seven of the E.coli strains tested against amikacin were susceptible. Of these seven isolates, three were tested against imipenem, out of which two were susceptible and one was resistant. Amikacin and imipenem were the most active antimicrobial agent against isolates of E.coli as found in other studies (27, 28) .
In conclusion, E.coli is the fourth most common bacteria isolated in the neonatal period in this study and third among the gram negative bacteria. Most were resistant to commonly used antibiotics for treatment of neonatal infections with a few showing resistant pattern resembling ESBLs producers. Most of the isolates were susceptible to amikacin and the carbapenems. In view of the limitation encountered in this study, a well designed prospective study; as well as continuous surveillance of antimicrobial resistance in E.coli isolates are hereby recommended.
